EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis

Susan E Smith iD, Rehana Bagodiya, Phuong Luong, Sakshi Shinde, Christopher M Bland iD, Christopher Barry, Michael G Bartlett iD, Nicholas R Fox, Trisha N Branan iD

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2026-06 · 46 (6)

DOI: 10.1002/phar.70152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, online erschienen am 12.05.2026. Verfasst von Susan E Smith und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Athens, Georgia, USA. Hauptthemen laut MEDLINE: Cefepime, Anti-Bacterial Agents, Sepsis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American College of Clinical Pharmacy, NIH National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intravenous push (IVP) administration of cefepime increases ease of preparation and limits the need for small volume parenterals. The data on IVP pharmacokinetic/pharmacodynamic (PK/PD) parameters are limited, but may be especially relevant in critically ill patients with altered PK/PD for time‐dependent antibiotics like cefepime. The objective of this study was to characterize the PK profile and PD target attainment of IVP cefepime in critically ill patients with sepsis.

Methods

In this institutional review board‐approved, prospective, noninterventional PK study, hospitalized adult patients receiving IVP cefepime were included if they had a central/midline catheter, intensive care unit (ICU) length of stay ≥ 48 h, creatinine clearance > 30 mL/min without renal replacement therapy, and diagnosis of sepsis. Blood samples were obtained at cefepime steady state immediately before and at 5, 15, 30, 60, 120, and 240 min after a dose. Serum concentrations of cefepime were measured using high‐performance liquid chromatography with ultraviolet detection. Patient characteristics and outcomes were collected retrospectively from the electronic health record. The primary outcome was the PK profile of cefepime following IVP administration.

Results

Patients ( n = 17) had a median age of 69 years, body mass index (BMI) of 29.9 kg/m 2 , creatinine clearance of 94 mL/min, and sequential organ failure assessment (SOFA) score of 9. Following IVP administration, PK analysis demonstrated a maximum concentration ( C max ) of 158 μg/mL, time to maximum concentration ( T max ) of 5 min, area under the curve ( AUC ) of 286.95 μg × h/mL, and elimination rate constant ( K e ) of 0.31 h −1 . Additionally, the analysis showed a volume of distribution of 43.91 L, elimination half‐life ( t ½ ) of 3.76 h, clearance ( CL ) of 7.86 L/h, and time above minimum inhibitory concentration ( T > MIC ) of 86%.

Conclusions

Intravenous push cefepime in critically ill patients achieved systemic exposure comparable to traditional intermittent infusion but demonstrated substantial interpatient PK variability. These findings highlight the impact of critical illness on cefepime disposition and support further evaluation of personalized cefepime dosing for the ICU population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CefepimeAnti-Bacterial AgentsSepsisHumansCritical IllnessFemaleAgedMaleMiddle AgedProspective StudiesInfusions, Intravenous

Stichwörter der Autor:innen

cefepimecephalosporinscritical illnesspharmacokineticssepsis syndromes

Substanzen

CefepimeAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Athens, Georgia, USA.
  • Department of Pharmaceutical and Biological Sciences, University of Georgia College of Pharmacy, Athens, Georgia, USA.
  • University of Georgia College of Pharmacy, Athens, Georgia, USA.
  • Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Savannah, Georgia, USA.
  • St. Joseph's/Candler Health System, Savannah, Georgia, USA.
  • AU/UGA Medical Partnership, Athens, Georgia, USA.

ORCID-Profile: Susan E Smith, Christopher M Bland, Michael G Bartlett, Trisha N Branan

Förderung

  • American College of Clinical Pharmacy
  • NIH National Institutes of Health

Zitieren

APA

Smith, S. E., Bagodiya, R., Luong, P., Shinde, S., Bland, C. M., Barry, C., Bartlett, M. G., Fox, N. R., & Branan, T. N. (2026). Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 46(6). https://doi.org/10.1002/phar.70152

Vancouver

Smith SE, Bagodiya R, Luong P, Shinde S, Bland CM, Barry C, et al. Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2026;46(6). doi:10.1002/phar.70152

BibTeX
@article{Smith2026,
  author = {Smith, Susan E and Bagodiya, Rehana and Luong, Phuong and Shinde, Sakshi and Bland, Christopher M and Barry, Christopher and Bartlett, Michael G and Fox, Nicholas R and Branan, Trisha N},
  title = {Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2026},
  volume = {46},
  number = {6},
  doi = {10.1002/phar.70152}
}
Kostenlos starten →